AI Science Tracker
EN

Deep learning from multiple experts improves identification of amyloid neuropathologies.

Affiliation not stated in the reviewed material · 28 Apr 2022 · medicine

Discovery

Deep learning from multiple experts improves identification of amyloid neuropathologies.

Source check: Source checked. Not independent scientific confirmation.

Finding: CNN ensembles combined five expert annotation schemes to identify amyloid neuropathologies, with held-out evaluation and a prospective blind research filter assessment.

Technology: Methods describe whole-slide image train/holdout split, four-fold models and expert ensembles; Results and prospective phase-two evaluate identification of cored plaques and cerebral amyloid angiopathy.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Methods describe whole-slide image train/holdout split, four-fold models and expert ensembles; Results and prospective phase-two evaluate identification of cored plaques and cerebral amyloid angiopathy.
Test and result
Methods describe whole-slide image train/holdout split, four-fold models and expert ensembles; Results and prospective phase-two evaluate identification of cored plaques and cerebral amyloid angiopathy.
Limitation / still unknown
Methods describe whole-slide image train/holdout split, four-fold models and expert ensembles; Results and prospective phase-two evaluate identification of cored plaques and cerebral amyloid angiopathy.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC9052651/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.